Dr Sushma Shivaswamy | Vice President, Research and Development
XBiotech | United States

Dr Sushma Shivaswamy, Vice President, Research and Development, XBiotech

Sushma Shivaswamy has been Vice President of Research and Development at XBiotech Inc. since January 2015. She joined the company in 2009 and previously served as Director, R&D between 2011 and 2015. Between 2009 and 2011, Sushma served as Senior Scientist. In her current role as VP, she leads teams involved in various Research & Development projects at XBiotech including Antibody Discovery, Cell Line Development, and pre-clinical toxicology and efficacy studies using animal models. Prior to joining XBiotech, Dr. Shivaswamy was a postdoctoral researcher at the Center for Systems and Synthetic Biology at the University of Texas at Austin. She has a Ph.D. degree in Molecular Biology from the Center for Cellular and Molecular Biology, India. Dr. Shivaswamy’s academic studies have involved elucidating mechanisms for regulation of gene expression.

Appearances:



DC Pre-congress WS day April 2 @ 09:00

Incorporating passive immunization with active immunization – The role and use mABs for infectious diseases

Should there really be a distinction between passive and active immunization when responding to diseases and infections therapeutically? Join this workshop to understand how these treatments are increasingly combined and the role of both passive and active immunization in future.

An overview of the scientific rationale & landscape survey of antibodies in preclinical and clinical development for infectious diseases

RSV and bacterial (Sa and Pa) prophylactic monoclonals in development

Current Sa antibodies used effectively for prophylaxis

True Human™ antibody therapy against C. difficile
 

back to speakers